Literature DB >> 22190153

Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings.

Jose de Leon1, Francisco J Diaz.   

Abstract

The association between schizophrenia and tobacco smoking has been described in more than 1,000 articles, many with inadequate methodology. The studies on this association can focus on: (1) current smoking, ever smoking or smoking cessation; (2) non-psychiatric controls or controls with severe mental illness (e.g., bipolar disorder); and (3) higher smoking frequency or greater usage in smokers. The association with the most potential for genetic studies is that between ever daily smoking and schizophrenia; it may reflect a shared genetic vulnerability. To reduce the number of false-positive genes, we propose a three-stage approach derived from epidemiological knowledge. In the first stage, only genetic variations associated with ever daily smoking that are simultaneously significant within the non-psychiatric controls, the bipolar disorder controls and the schizophrenia cases will be selected. Only those genetic variations that are simultaneously significant in the three hypothesis tests will be tested in the second stage, where the prevalence of the genes must be significantly higher in schizophrenia than in bipolar disorder, and significantly higher in bipolar disorder than in controls. The genes simultaneously significant in the second stage will be included in a third stage where the gene variations must be significantly more frequent in schizophrenia patients who did not start smoking daily until their 20s (late start) versus those who had an early start. Any genetic approach to psychiatric disorders may fail if attention is not given to comorbidity and epidemiological studies that suggest which comorbidities are likely to be explained by genetics and which are not. Our approach, which examines the results of epidemiological studies on comorbidities and then looks for genes that simultaneously satisfy epidemiologically suggested sets of hypotheses, may also apply to the study of other major illnesses.

Entities:  

Mesh:

Year:  2011        PMID: 22190153      PMCID: PMC3536540          DOI: 10.1007/s00439-011-1122-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  133 in total

1.  The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being.

Authors:  L Degenhardt; W Hall
Journal:  Psychol Med       Date:  2001-05       Impact factor: 7.723

2.  The association between schizophrenia and smoking: unexplained by either the illness or the prodromal period.

Authors:  Francisco J Diaz; Diana M Velásquez; Margaret T Susce; Jose de Leon
Journal:  Schizophr Res       Date:  2008-07-22       Impact factor: 4.939

3.  Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

Authors:  A Olincy; D A Young; R Freedman
Journal:  Biol Psychiatry       Date:  1997-07-01       Impact factor: 13.382

4.  Differences in smoking expectancies in smokers with and without a history of major depression.

Authors:  Andrea H Weinberger; Tony P George; Sherry A McKee
Journal:  Addict Behav       Date:  2010-12-28       Impact factor: 3.913

5.  Smoking initiation and schizophrenia: a replication study in a Chinese Han population.

Authors:  Xiang Yang Zhang; Cun Bao Li; Min Li; You Lan Zheng; Chong Xi Zhang; Quan Zhi Yan; Wen Zhong Liu; Yi Min Kang; Fan Wang; Da Chun Chen; Mei Hong Xiu; Thomas R Kosten
Journal:  Schizophr Res       Date:  2010-06       Impact factor: 4.939

6.  Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.

Authors:  Peter F Buckley
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

7.  A population-based twin study of the genetic and environmental relationship of major depression, regular tobacco use and nicotine dependence.

Authors:  A C Edwards; H H Maes; N L Pedersen; K S Kendler
Journal:  Psychol Med       Date:  2010-04-21       Impact factor: 7.723

8.  Cigarette smoking, nicotine dependence, and motivation for smoking cessation in psychiatric inpatients.

Authors:  Heidi Solty; David Crockford; William D White; Shawn Currie
Journal:  Can J Psychiatry       Date:  2009-01       Impact factor: 4.356

Review 9.  Psychiatric comorbidities and schizophrenia.

Authors:  Peter F Buckley; Brian J Miller; Douglas S Lehrer; David J Castle
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

10.  Mechanisms underlying the lifetime co-occurrence of tobacco and cannabis use in adolescent and young adult twins.

Authors:  Arpana Agrawal; Judy L Silberg; Michael T Lynskey; Hermine H Maes; Lindon J Eaves
Journal:  Drug Alcohol Depend       Date:  2010-01-04       Impact factor: 4.492

View more
  11 in total

1.  Premature to conclude no genetic basis to the association between smoking and major depressive disorder.

Authors:  David Lawrence; Francis Mitrou; Stephen R Zubrick
Journal:  Hum Genet       Date:  2012-04-13       Impact factor: 4.132

2.  Cigarette Smoking and Health Characteristics in Individuals With Serious Mental Illness Enrolled in a Behavioral Weight Loss Trial.

Authors:  Faith B Dickerson; Airong Yu; Arlene Dalcin; Gerald J Jerome; Joseph V Gennusa; Jeanne Charleston; Rosa M Crum; Leslie Campbell; Meghan Oefinger; Lawrence J Appel; Gail L Daumit
Journal:  J Dual Diagn       Date:  2013-01-01

3.  The effects of prenatal stress on alpha4 beta2 and alpha7 hippocampal nicotinic acetylcholine receptor levels in adult offspring.

Authors:  Kalynn M Schulz; Kristin M Andrud; Maria B Burke; Jennifer N Pearson; Alison D Kreisler; Karen E Stevens; Sherry Leonard; Catherine E Adams
Journal:  Dev Neurobiol       Date:  2013-09-17       Impact factor: 3.964

4.  The insertion/deletion polymorphism in the angiotensin-converting enzyme gene and nicotine dependence in schizophrenia patients.

Authors:  Sergej Nadalin; Smiljana Ristić; Jelena Rebić; Vesna Šendula Jengić; Miljenko Kapović; Alena Buretić-Tomljanović
Journal:  J Neural Transm (Vienna)       Date:  2016-12-27       Impact factor: 3.575

5.  The genetics of addiction.

Authors:  Nora D Volkow; Maximilian Muenke
Journal:  Hum Genet       Date:  2012-06       Impact factor: 4.132

6.  Genetic Relationship between Schizophrenia and Nicotine Dependence.

Authors:  Jingchun Chen; Silviu-Alin Bacanu; Hui Yu; Zhongming Zhao; Peilin Jia; Kenneth S Kendler; Henry R Kranzler; Joel Gelernter; Lindsay Farrer; Camelia Minica; Rene Pool; Yuri Milaneschi; Dorret I Boomsma; Brenda W J H Penninx; Rachel F Tyndale; Jennifer J Ware; Jacqueline M Vink; Jaakko Kaprio; Marcus Munafò; Xiangning Chen
Journal:  Sci Rep       Date:  2016-05-10       Impact factor: 4.379

7.  Nicotine dependence in Croatian male inpatients with schizophrenia.

Authors:  Marina Šagud; Bjanka Vuksan-Ćusa; Nenad Jakšić; Alma Mihaljević-Peleš; Maja Živković; Suzana Vlatković; Tea Prgić; Darko Marčinko; Wei Wang
Journal:  BMC Psychiatry       Date:  2018-01-22       Impact factor: 3.630

8.  Identification of 34 genes conferring genetic and pharmacological risk for the comorbidity of schizophrenia and smoking behaviors.

Authors:  Yunlong Ma; Jingjing Li; Yi Xu; Yan Wang; Yinghao Yao; Qiang Liu; Maiqiu Wang; Xinyi Zhao; Rongli Fan; Jiali Chen; Bin Zhang; Zhen Cai; Haijun Han; Zhongli Yang; Wenji Yuan; Yigang Zhong; Xiangning Chen; Jennie Z Ma; Thomas J Payne; Yizhou Xu; Yuping Ning; Wenyan Cui; Ming D Li
Journal:  Aging (Albany NY)       Date:  2020-02-03       Impact factor: 5.682

9.  Motivations to quit smoking and challenges faced during cessation among individuals with first episode psychosis in Singapore.

Authors:  Vathsala Sagayadevan; Edimansyah Abdin; Shazana Shahwan; Pratika Satghare; Fiona Devi; Laxman Cetty; Jagan R Sendren; Swapna K Verma; Siow Ann Chong; Mythily Subramaniam
Journal:  Early Interv Psychiatry       Date:  2019-03-28       Impact factor: 2.732

10.  Role of Statistical Random-Effects Linear Models in Personalized Medicine.

Authors:  Francisco J Diaz; Hung-Wen Yeh; Jose de Leon
Journal:  Curr Pharmacogenomics Person Med       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.